STUART LEWIS J

Track

Insider profile

STUART LEWIS J's trades of Cymabay Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
421.56
Quantity 24,253
Value US$3,863,402
Transaction date
Proposed sale
Price
64.38
Quantity 42,011
Value US$1,866,076
Transaction date
Proposed sale
Price
80.48
Quantity 16,830
Value US$1,834,453
Transaction date
Proposed sale
Price
23.40
Quantity 60,749
Value US$1,421,527
Transaction date
Proposed sale
Price
23.40
Quantity 40,158
Value US$939,697
Transaction date
Proposed sale
Price
24.25
Quantity 337,583
Value US$8,186,388
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-02-06 2024-02-06
PrS Proposed sale
24,253
421.56
US$3,863,402 		24,253 421.56 US$3,863,402
2024-01-22 2024-01-22
PrS Proposed sale
42,011
64.38
US$1,866,076 		42,011 64.38 US$1,866,076
2024-01-19 2024-01-19
PrS Proposed sale
16,830
80.48
US$1,834,453 		16,830 80.48 US$1,834,453
2024-01-18 2024-01-18
PrS Proposed sale
60,749
23.40
US$1,421,527 		60,749 23.40 US$1,421,527
2024-01-17 2024-01-17
PrS Proposed sale
40,158
23.40
US$939,697 		40,158 23.40 US$939,697
2024-01-03 2024-01-03
PrS Proposed sale
337,583
24.25
US$8,186,388 		337,583 24.25 US$8,186,388